Document is current
Any future updates will be listed below
-
Authors
Nygaard, Hanne https://orcid.org/0000-0001-8609-8755
Kamper, Rikke S. https://orcid.org/0000-0002-1927-9078
Nielsen, Finn E. https://orcid.org/0000-0002-7650-6927
Hansen, Sofie K. https://orcid.org/0000-0003-0594-3553
Hansen, Pernille https://orcid.org/0009-0004-5545-1105
Wejse, Miriam R.
Pressel, Eckart
Rasmussen, Jens
Suetta, Charlotte https://orcid.org/0000-0001-8063-6508
Ekmann, Anette https://orcid.org/0000-0002-9890-4707
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052826)
Copenhagen University
- License Information
-
More Information
Article History
Received: 5 February 2024
Accepted: 8 September 2024
First Online: 28 September 2024
Declarations
:
: HN, RSK, FN, SKH, PH, MRW, EP, JR, CS, and AE declare no conflict of interest. The authors have no relevant financial or non-financial interests to disclose.
: All parts of the trial procedures are performed in accordance with the Declaration of Helsinki. The study protocol was approved by the local ethics committee of Copenhagen and Frederiksberg. (ID: H-19039214). The Copenhagen PROTECT Study is registered at clinicaltrials.gov with the trial registration ID: NCT04151108.
: All included patients provided written informed consent.
